2017 Market For Cell Therapy Manufacturing – Strategies for Pricing, Cost Control, Reimbursement, Distribution, & More
https://www.aboutpharma.com/blog/20...cost-control-reimbursement-distribution-more/
quote >>>
This global strategic report provides detailed analysis of ten leading cell therapy companies worldwide, evaluating the strengths of each company, as well as identifying cell therapy products in development, manufacturing strategies, and partnerships.
These companies include:
- ReNeuron
- Mesoblast Ltd.
- Asterias Biotherapeutics
- TiGenix NV
- Cellectis
- Cynata Therapeutics
- Cytori Therapeutics
- Astellas Pharma (and Subsidiary Ocata Therapeutics)
- Gamida Cell Ltd.
- Pluristem Therapeutics
Ann: Cynata to Increase Exposure in Japan, page-35
-
- There are more pages in this discussion • 46 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
23.0¢ |
Change
-0.005(2.13%) |
Mkt cap ! $41.55M | |||
| Open | High | Low | Value | Volume |
| 23.5¢ | 23.5¢ | 23.0¢ | $18.19K | 78.25K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 62836 | 23.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 24.0¢ | 15000 | 3 |
View Market Depth
| Last trade - 13.38pm 04/11/2024 (20 minute delay) ? |
| CYP (ASX) Chart |